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Available online 1 December 2015Amajor challenge to the study and treatment of neurogenetic syndromes is accessing live neurons for study from
affected individuals. Although several sources of stem cells are currently available, acquiring these involve inva-
sive procedures, may be difﬁcult or expensive to generate and are limited in number. Dental pulp stem cells
(DPSCs) are multipotent stem cells that reside deep the pulp of shed teeth. To investigate the characteristics of
DPSCs thatmake them a valuable resource for translational research, we performed a set of viability, senescence,
immortalization and gene expression studies on control DPSC and derived neurons. We investigated the basic
transport conditions and maximum passage number for primary DPSCs. We immortalized control DPSCs using
human telomerase reverse transcriptase (hTERT) and evaluated neuronal differentiation potential and global
gene expression changes by RNA-seq. We show that neurons from immortalized DPSCs share morphological
and electrophysiological properties with non-immortalized DPSCs. We also show that differentiation of DPSCs
into neurons signiﬁcantly alters gene expression for 1305 transcripts. Here we show that these changes in
gene expression are concurrent with changes in protein levels of the transcriptional repressor REST/NRSF,
which is known to be involved in neuronal differentiation. Immortalization signiﬁcantly altered the expression
of 183 genes after neuronal differentiation, 94 of which also changed during differentiation. Our studies indicate
that viable DPSCs can be obtained from teeth stored for ≥72 h, these can then be immortalized and still produce
functional neurons for in vitro studies, but that constitutive hTERT immortalization is not be the best approach for
long term use of patient derived DPSCs for the study of disease.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Senescence1. Introduction
In order to understand the molecular and physiological changes in
neurons of the brains of individuals with disorders ranging from intel-
lectual disability to autism, it is essential to study live neurons that accu-
rately represent the conditions in the brain in the disease state. A
signiﬁcant challenge to the study of both rare and common neuro-
genetic syndromes is the inability to access live neurons for study in
the laboratory setting. One recent approach to overcome this problem
has been the collection of skin biopsies from individuals with neuro-
genetic disease in order to create ﬁbroblast cell lines, which are then, The University of Tennessee
his, TN 38163, United States.
. This is an open access article underinduced into pluripotency using viral constructs to become pluripotent
stem cells (iPSCs), before ﬁnally being differentiated downneuronal lin-
eages in culture (Marchetto et al., 2010). This approach is limited by the
fact that iPSCs can be difﬁcult to generate, are often restricted in their
downstream differentiation potential and can take a long time to differ-
entiate into representative neurons (Arbab et al., 2014). One solution to
these problems is to obtain biospecimens of multipotent neuronal pre-
cursor cells, which are already destined to become neurons and there-
fore do not need reprogramming. Mammalian dental pulp is a neural
crest-derived tissue and has been shown to contain a potent population
of stem cells with neurogenic potential both in vitro and in vivo
(Abraham and Verfaillie, 2012; Achilleos and Trainor, 2012). These
stem cells can respond to local microenvironment cues in the mamma-
lian brain to become a variety of central nervous system cell types
(Kiraly et al., 2011) and have been shown to respond to neuronalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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extracted primary teeth (baby teeth) are a good source for dental pulp
stem cells (DPSCs), and are easy to collect even from remote locations.
This is an important practical consideration for the study of rare dis-
orders, where the logistics required to create a single collection of
cell lines from a variety of remote locations can be prohibitive, and
more so when generating enough samples to overcome the normal
genetic heterogeneity and gene expression variation found in
human populations.
The process of generating neurons from tooth pulp neural precur-
sors is now well tested in control samples (Kiraly et al., 2011; Arthur
et al., 2008; Kiraly et al., 2009; Nosrat et al., 2004), but it has never
been used before to establish a large repository of samples for the
study of neurogenetic syndromes. Currently, there are no standardized
protocols for long-term storage and transportation of extracted teeth
for the production of DPSCs. The evaluation of factors such as storage
conditions, transport time and cellular senescence of primary DPSCs is
crucial to the development of DPSCs as a resource for the broader
study of neurogenetic disease. In this study, DPSCs have been grown
under various conditions and immortalized with a human telomerase
reverse transcriptase (hTERT) retrovirus soon after processing. Here, we
assess how storage conditions, processing time, and the timing of im-
mortalization affect the success of the immortalization process. In addi-
tion, immortalized DPSCs were evaluated for their ability to efﬁciently
form DPSC neurons that electrophysiologically and morphologically re-
semble non-immortalized DPSC neurons. Finally, using whole genome
RNA-seq analysis, we established that the immortalized DPSCs and
DPSC neurons are molecularly similar to non-immortalized primary
DPSCs at the gene expression level. These studies indicate that teeth
can be obtained from distant locations as much as 72 h away and still
produce viable DPSCs which, when immortalized using hTERT, are sim-
ilar in many ways to non-immortalized DPSCs. These are the ﬁrst steps
in the development of a protocol to successfully obtain DPSCs from any
individual with any neurogenetic syndrome anywhere in the world
with the eventual goal of creating a repository of immortalized DPSC
lines that can be used to study nervous system disorders at the molecu-
lar and physiologic level.
2. Materials and methods
2.1. Generation of DPSC lines
Teeth were obtained through the Department of Pediatric Dentistry
at the University of Tennessee Health Science Center (UTHSC). The
UTHSC Institutional Review Board approved this study and informed
consent was obtained from the parent or legal guardian of all partici-
pants. Participants did not receive a dental cleaning prior to tooth dona-
tion in the clinic. Immediately following extraction of a loose tooth in
the clinic, the tooth was placed in transportation media (DMEM/F12
50/50 mix with HEPES (Fisher Scientiﬁc) and 100 U/mL penicillin,
100 μg/mL streptomycin). DPSCs were isolated and culture as previous-
ly described with slight modiﬁcations (Kiraly et al., 2009). Brieﬂy, the
pulp was minced and digested in a solution of 3 mg/mL Collagenase
type I and 4 mg/mL Dispase II for 1 h at 37 °C. Cells were seeded in
poly-D-lysine 12-well dishes andmaintained under standard conditions
(37 °C, 5% CO2) in DMEM/F12 1:1, 10% fetal bovine serum (Fisher Scien-
tiﬁc), 10% newborn calf serum (NCS) (Fisher Scientiﬁc) and 100 U/mL
penicillin, 100 μg/mL streptomycin (Pen/Strep). Sub-conﬂuent cultures
were passaged regularly with 0.1 μM HyQTase (HyClone).
2.2. Evaluation of cellular senescence in DPSCs
Senescence testing was performed following the Senescence Cell
Histochemical Staining Kit protocol (Sigma-Aldrich). The assay is
based on a histochemical stain for senescence-associated β-
galactosidase (β-gal) activity at pH 6. Each DPSC line was washedtwice in 1× PBS, 400-μL-ﬁxation buffer was added to each DPSC
line and incubated for 7 min at room temperature. The staining so-
lution had 250 μL of stock X-gal solution, and 400 μL of staining so-
lution was added to each sample according to the manufacturer's
protocol. The samples were incubated at 37 °C without CO2 until
the cells appeared blue (approximately 18 h). After the incubation
the cells were rinsed twice in 1× PBS and counterstained with
Eosin (Sigma-Aldrich) for 8 min. Cells were viewed under a light
microscope and cells stained with blue were counted as senescent.
For each time point, at least 500 cells were counted to determine
the percentage of senescent cells.2.3. Immortalization of primary DPSCs
Immortalization was performed as described previously (Egbuniwe
et al., 2011). 1 × 104 cells were plated in a poly-D-lysine coated 12-
well dish and infected with pBABE-hTERT-Puro® retrovirus at a multi-
plicity of infection of 20 plus 6 μg/mL Polybrene for 24 h. The virus
was removed and replacedwith growthmedia for a 72–90 hour period.
After this period, the infected DPSCs were selected by adding 1 μg/mL
puromycin for 7–10days. TheDPSCs that survived this processwere im-
mortalized DPSCs and were ready for differentiation into neurons.2.4. Neural differentiation
DPSCs were converted to neurons according to a previously pub-
lished protocol (Kiraly et al., 2009). 20,000 cells/cm2 were seeded in
poly-D-lysine coated 12 well plates or T-25 ﬂasks in DMEM/F12 (1:1),
2.5% fetal calf serum (FCS), 100 U/mL penicillin and 100 μg/mL strepto-
mycin, and cultured for 24 h. Epigenetic reprogrammingwas performed
by exposing the DPSCs to 10 μM 5-azacytidine (Acros Scientiﬁc) in
DMEM/F12 containing 2.5% fetal calf serum (Fisher Scientiﬁc) and
10 ng/mL bFGF for 48 h. Neural differentiationwas induced by exposing
the cells to 250 μM IBMX, 50 μM forskolin, 200 nMTPA (Sigma-Aldrich),
1 mM db-cAMP, 10 ng/mL bFGF, 10 ng/mL NGF (Invitrogen), 30 ng/mL
NT-3 (Peprotech), and 1% insulin–transferrin–sodium selenite premix
(ITS) in DMEM/F12 for 3 days. At the end of the neural induction treat-
ment, the cells were washed with 1× PBS. Neuronal maturation was
performed bymaintaining the cells in Neurobasal A media (Invitrogen)
supplemented with 1 mM dbcAMP, 1% N2, 1% B27, and 30 ng/mL NT-3
and 1× Glutamax for 3 weeks.2.5. Western blot analysis
Proteinwas extracted fromDPSCs and neurons using radioimmuno-
precipitation assay (RIPA) lysis buffer for DPSCs or neuronal protein ex-
traction reagent for neurons (Thermo Fisher Scientiﬁc). Samples were
resolved on a NuPage 1.5 mm 4–12% Bis–Tris or a 3–8% Tris–Acetate
gel according to manufacturers instructions (Invitrogen) and trans-
ferred to Immobilon-FL PVDF membrane (Millipore). The membrane
was blockedwith 5% BSA, and 0.2% Tween-20 in Phosphate Buffered Sa-
line (PBS). Primary antibodies used include α-GAPDH (dilution 1:5000
from Novus Biologicals catalog#: IMG-3073), α-REST (dilution 1:2500
from Bethyl Laboratories Inc. catalog#: A300-540A), α-MAP2 (dilution
1:10,000 from Abcam catalog#: ab5392) and α-GFAP (dilution 1:1500
from Abcam catalog#: ab7260). Infrared (IR) labeled secondary anti-
bodies purchased from Li-Cor (Lincoln, NE) and used in a 1:5000
dilution (α-rabbit 680, α-goat 800 and α-chicken 680). The blot was
imaged and analyzed using the Odyssey Infrared Imaging System (Li-
Cor, Lincoln, NE). After adjustment for background ﬂuorescence, lanes
were normalized using the signal from the α-GAPDH loading control
as the reference channel and signal intensity was then adjusted based
on the calculated normalization factor assigned to each lane in the
channel.
Table 1
Groups used for storage studies.
Group Tooth Stored Processed
1 Extracted 4 °C b24 h
2 Extracted 4 °C N72 h
3 Extracted RT N72 h
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2.6.1. Whole-cell patch recordings
Patch electrodes were fabricated from soda lime capillary glass
(Scientiﬁc Products, B4416-1) using a Narishige 2-stage vertical puller,
coated with Sylgard (Dow Corning) to about 200 μm from the tip, and
ﬁre polished to a ﬁnal resistance of 0.8–2.0 MΩ, using a Narishige
microforge. The patch electrodes were ﬁlled with a solution containing:
140 mM CsF, 1 mMMgCl2, 10 mMNaCl, 11 mM ethylene glycol-bis (β-
aminoethylether)-N,N,N′,N′,-tetraacetic acid (EGTA), and 10mM(N-[2-
hydroxyethyl]piperazine-N′-[2-ethanesulfonic acid]) (HEPES), adjusted
to pH 7.2 with CsOH. Giga-ohm seals and recordings were obtained in
Tyrode's solution containing 140 mM NaCl, 4 mM KCl, 2 mM MgCl2,
2 mM CaCl2, 10 mM glucose, 10 HEPES, adjusted to pH 7.4 with NaOH.
2.6.2. Data acquisition
Data acquisition was carried out using Clampex 8.2 (Axon Instru-
ments) commanding an Axopatch 2A interfaced to the computer with
a 1322A series Digidata (Axon Instruments). The ampliﬁer was tuned
to null whole-cell capacitance and optimized clamp speed and series re-
sistance (Rs) compensation. Prediction and Rs compensationwere set to
80–85%. Data were ﬁltered at 5 kHz, and all Na+ currents were leak
subtracted using the P/4 method. I–V relationships were generated by
holding the DPSC cells at−80 mV and giving 20 ms test potentials to
−75 through +70 mV.
2.7. RNA sequencing
Total RNA was extracted from ~3 week cultured neurons and DPSCs
using themiRNeasyMini kit (Qiagen). Total RNAwas checked for quan-
tity and quality on an Agilent Bioanalyzer 6000 Pico chip and deter-
mined to have an RNA Integrity Number (RIN) of ≥8.0. NuGen
ampliﬁed material was sheared on a Covaris S2 with a duty cycle of
10%, intensity of 5100 cycles/burst, and 6 × 60 s cycles (total processing
time 6min). 500 ng of this sheared double strand DNAwas then used to
prepare libraries for sequencing using the Ion plus Core Library Module
for AB Library Builder System. Libraries were used from this point with-
out ampliﬁcation. Before sequencing, small aliquots of this material
were pooled and sequenced on an Ion Torrent PGM 314 chip. Barcode
quantiﬁcation data from the PGM were used to balance the samples
for ﬁnal pooling before sequencing. Following this ﬁnal pooling the li-
brary pools were sized to a target size of 260 bp on a Pippin Prep instru-
ment. The sized libraries were examined on an Agilent High Sensitivity
DNA chip, quantiﬁed using real-time PCR, and used to prepare spheres
using a One-Touch 2 device. These spheres were then sequenced on
an Ion Torrent Proton sequencer with a P1 chip. On average, ~30million
reads were produced per sample for downstream analysis resulting in
≥7.6 million mapped reads per sample.
2.8. RNA-seq analysis
Short transcript fragmentsweremapped to the reference human ge-
nome (GRCh38; accession number GRCh38.77) using TopHat v2.0.13
(Kim et al., 2013) with Bowtie v2.1.0 (Langmead et al., 2009) and
Samtools v0.1.19. The complete sequencing read dataset is available at
the NCBI Gene Expression Omnibus (GEO) site (http://www.ncbi.nlm.
nih.gov/geo) using the GEO:GSE67124 accession number. These align-
ments used reference annotation based alignments against the
GENCODE v21 transcriptome. Mapped reads were indexed to known
genes using HTseq v0.6.1 (Anders et al., 2014). Differentially expressed
transcripts were identiﬁed using the DESeq2 bioconductor package
(Love et al., 2014). Heatmaps were generated using the R software
package (v 3.1.1) (R Core Team, 2013). Venn diagrams were generated
online using Gene List Venn Diagram software (http://genevenn.
sourceforge.net/) Additional descriptive analysis was performed using
Gene Set Enrichment Analysis (GSEA) using a rank ordered gene listbased on fold change to identify pathways and transcription factor bind-
ing motifs enriched in particular datasets (Subramanian et al., 2005).
Statistical signiﬁcance for GSEA analysis was set at q ≤ 0.25 as per the
developer's suggestion. These gene sets were obtained from MSigDB
version 4.0. Gene sets that were found to be signiﬁcantly up- or
down-regulated (q ≥ 0.05) were also analyzed as a gene list with de-
fault stringency settings using The Database for Annotation, Visuali-
zation and Integrated Discovery (DAVID v6.7) (http://david.abcc.
ncifcrf.gov/).
3. Results
Teeth were collected from 10 female and 6 male subjects. The
subject ages ranged from 6 to 13 years old, with an average age of
9. All subjects were typically developing children with no suspicion
of undiagnosed neurogenetic disorders. The teeth included in the
study were non-carious, had no previous restorations, and had no re-
ports of prior facial or dental trauma. At the time of collection in the
clinic, there was a general assessment of oral hygiene from poor to
excellent. A total of 16 healthy extracted teeth were processed.
3.1. Evaluations of storage and processing time from tooth to cell line
To investigate the optimal conditions for transportation and process
time of the teeth, we stored and processed them at 3 different time in-
tervals. Teeth were randomly assigned to a group for viability studies
(Table 1). Cells were considered viable if they grew to conﬂuence after
4 weeks in culture. Viability and morphology were checked using a
light microscope to determine which transportation conditions and
process times yielded the best results. On average, there was a 56% suc-
cess rate in culturing DPSCs with no signiﬁcant differences among the
three groups (Fisher's Exact Test, Pvalue ≥ 0.05). Those teeth that failed
to grow DPSCs were contaminated or did not grow after 4 weeks. Two
samples from group 1 became contaminated. One sample from group
2 became contaminated and two samples did not grow one month
after processing. In group 3, two samples did not grow and one sample
became contaminated. In all cases, these contaminants appear to have
come from the mouth despite the use of both penicillin and streptomy-
cin in the transport media. A total of 8 samples failed to grow in this
study: 3 from subjects with good oral hygiene and 5 from subjects
with fair oral hygiene. Good oral hygiene is deﬁned as no visible plaque
and nobleeding on probing. Fair oral hygiene is demonstrated by gener-
alized plaque not covering more than 25% of the teeth with or without
bleeding on probing. There were almost twice as many failures from
samples with fair oral hygiene verses subjects with good oral hygiene.
These experiments indicate that teeth stored at RT for N72 h appear to
make viable DPSCs just as efﬁciently as those stored under more favor-
able conditions.
3.2. Longevity of non-immortalized DPSC lines
In order to develop DPSCs as amodel system in the lab for long term
studies we investigated the growth potential of primary DPSCs. To de-
termine the rate of cellular senescence and the passage when primary
DPSCs stop dividing we used a senescence-associated β-galactosidase
assay to identify the percentage of senescent cells in four DPSC lines
frompassage 2 to passage 15 in culture (Fig. 1A). Cellular senescence in-
creased at a steady rate until passage 13 when percentage of senescent
Fig. 1. Senescence-associatedβ-galactosidase assay. A)At each passage cellswere stainedwithβ-gal (blue) and counterstainedwith Eosin (red). Only blue cellswere counted as ameasure
of senescence. Arrows point to deﬁnitively blue cells. B) 4 DPSCs (TP-023, TP-030A, TP-037A and TP-040) underwent senescence testing frompassage 2–15. At each passage therewas an
increase in the number of senescent cells. After passage 13, N93% of the cells were senescent except for TP-023,which appears to have immortalized in culture and continued to growwell
past passage 25.
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030A) completely stopped dividing by passage 14, while two other
lines (TP-040 and TP-023) survived this crisis stage and began to divide
again, decreasing the percentage of senescent cells to as low as 40% in
both cell lines in subsequent passages. These two cell lines appear to
have spontaneously immortalized and their tumorigenic potential was
evaluated inmice in a different study (Wilson et al., 2015). Themean se-
nescence rate for the four samples at passage 2was22.8% and at passage
13was 93.6%. These studies indicate that unless the lines become spon-
taneously immortalized, which most likely has genome wide effects on
their characteristics, the primaryDPSCswill not continue to grow in cul-
ture for more than 13 passages and therefore cannot be used long term
for laboratory studies without further modiﬁcation.
3.3. Optimal immortalization of DPSC lines with telomerase
reverse transcriptase
It has previously been shown that DPSCs can be immortalized using
a viral vector containing human telomerase reverse transcriptase (hTERT)
(Egbuniwe et al., 2011). We wanted to validate these results and then
further investigate morphological, electrophysiological and gene ex-
pression changes in immortalized vs. non-immortalized DPSCs and
DPSC derived neurons. Seven different DPSC cell lines were immortal-
ized between P2 and P5. After P6, all cell lines died during Puromycin
treatment, meaning that infection of these cells with the hTERT virus
failed in DPSCs ≥P6 (Table 2). Cells at ≤P2 were the most likely to be-
come stably infected with the virus with 86% of cell lines successfullyTable 2
Transduction of DPSCs with hTERT in different passages.
DPSC ID P2 P3 P4 P5 P6
TP-016 + − − − n/a
TP-030B − − − − n/a
TP-039 − − − − n/a
TP-024A + + − − n/a
TP-024B + + − − n/a
TP-027A + + + + −
TP-027B + + + + −
86% 57% 28% 28% 0%
(+) = Immortalized; (−) = cell die; n/a = not available.immortalized. We conﬁrmed the cells were immortalized by qRT-PCR
for hTERT. hTERT levels were high in immortalized DPSC cell lines, but
hTERT transcripts could not be detected in non-immortalized DPSCs by
qRT-PCR (data not shown). More extensive gene expression analysis
was performed by RNA-seq that clearly conﬁrmed these results (see
below).
3.4. Neural differentiation of immortalized DPSCs and
non-immortalized DPSCs
Three immortalized DPSCs and 3 non-immortalized DPSCs were
converted successfully to neurons. Immortalized DPSC–neurons and
non-immortalized DPSC–neurons were compared at 3 weeks and
7 weeks of maturation by light microscopy and appear morphologically
identical (Fig. 2A). In addition, there was a substantial increase in the
protein levels of the neuron speciﬁc marker MAP2 in neurons versus
DPSCs concurrentwith a decrease in the amount of the astroglial specif-
ic GFAP proteinmarker detected in differentiated neurons (Fig. 2B). Pre-
vious studies have shown that DPSC neurons not only morphologically
appear like neurons, but also exhibit Na+ currents (Kiraly et al., 2011;
Kiraly et al., 2009) when stimulated with a sharp electrode. We were
able todetect Na+ currents in both non-immortalized and immortalized
DPSCs at roughly equal frequency (Fig. 3A–C). Both non-immortalized
and immortalized neurons displayed similar apparent activation
thresholds averaging−33mVand−38mV, respectively, and peak am-
plitudes averaging 539 pA and 738 pA, respectively, with no signiﬁcant
difference between the two groups (Supplemental Fig. 1). These cur-
rents demonstrate that immortalization does not substantially affect
the ability of DPSCs to differentiate into cultured neurons with measur-
able activity.
Additional experiments were performed to determine if immortal-
ized DPSCs could differentiate into both osteocytes and adipocytes as
previously reported (Abuarqoub et al., 2015; Gibellini et al., 2015). In
a supplemental publication, we demonstrate that DPSCs can efﬁciently
differentiate into osteocytes, but that osteogenesis is ~60% less efﬁcient
using immortalizedDPSCs (El-Iyachi et al., 2015). Adipogenesiswas suf-
ﬁciently inhibited in both non-immortalized and immortalizedDPSCs as
well, but these cells were not pre-sorted for adipogenic markers in a
previous study (Gibellini et al., 2015). These data suggest that consti-
tutive expression of hTERT to immortalize DPSCs causes a signiﬁcant
reduction in the ability of these stem cells to differentiate into oste-
ocytes and adipocytes (El-Iyachi et al., 2015).
Fig. 2. Immortalized DPSC neurons are grossly indistinguishable from non-immortalized DPSC neurons. A) Morphology of immortalized DPSC neurons viewed at 4× magniﬁcation by
bright-ﬁeld. Note the long neuronal projections in both immortalized and non-immortalized DPSC neurons. B) Neuron and astroglial speciﬁc marker analysis in DPSC neurons from
two different DPSC lines (TP-023 and TP-037). The neuronal speciﬁc markerMAP2was detected by IRWestern blot in neurons usingα-MAP2 (red signal, top), but not DPSCs, regardless
of the immortalization state (top, red band). Shown in green is an α-GAPDH loading control that shows the presence of protein in each lane. The astroglial speciﬁc marker GFAP was
detectable in undifferentiated DPSCs using α-GFAP (red signal, lower blot) but decreased substantially in differentiated neurons.
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DPSC neurons
Typical control DPSC lines were immortalized with hTERT as previ-
ously described (Egbuniwe et al., 2013). Both the immortalized and
non-immortalized versions of these cell lines were grown to conﬂuence
for total RNA extraction. Early passages (P2 or P3) of these lines were
also differentiated into neurons alongside the immortalized versions
of these lines. Total RNA was extracted from 3 cell lines in each group:
DPSCs, DPSCs immortalized, 3 week old neurons, and 3 week old im-
mortalized neurons. Principal component analysis indicated that differ-
entiation of the DPSCs into neurons is the main dividing factor
differentiating the gene expression in these cell lines since all DPSCs
clustered together and all neurons derived from DPSCs clustered to-
gether regardless of immortalization status (Fig. 4A).
Transcript abundance was evaluated based on three comparisons:
DPSCs vs. neurons, DPSCs immortalized vs. non-immortalized and neu-
rons immortalized vs. non-immortalized. 1305 transcripts were differ-
entially regulated (577 up and 731 down at a normalized Pvalue ≤ 0.05)
during the process of differentiation from DPSCs to neurons (Fig. 4B).Fig. 3. Electrophysiological analysis of immortalized DPSC neurons. A) Family of Na+ currents e
Note that theNa+ currents evoked from immortalized DPSC neurons (B) did not differ from tho
DPSC neurons did not differ in peak amplitude, threshold or frequency. (C) I–V plot of Na+ curre
(A). All recordings were carried out with 140 mM Na+ outside and CsF or CsCl in the pipette.Among these transcripts, 94 genes showed differential expression both
during the differentiation process from DPSCs to neurons and were
signiﬁcantly different between immortalized and non-immortalized
neurons (Fig. 4B). By contrast, only 5 transcripts were differentially reg-
ulated in immortalized vs non-immortalized DPSCs. Two of these genes
were in common between both immortalized neurons and immortal-
ized DPSCs: the human TERT (telomerase reverse transcriptase) gene
which was inserted into the cell lines for immortalization which in-
creased in both DPSCs and neurons; and theGAS7 (growth arrest specif-
ic gene 7) which is thought to play a role in neurite outgrowths and
neurotransmission. This gene was decreased by immortalization in
both DPSCs and neurons. A complete list of differentially expressed
genes is available in Supplemental Tables 1–3.
A heatmap of gene expression changes that occur during differenti-
ation indicates that more transcripts (55.9%) were down-regulated
rather than up-regulated (44.1%) during the transition from DPSCs to
neurons (Fig. 5A). Gene set enrichment analysis (GSEA) of the tran-
scripts that changed during differentiation indicates that many of
these genes are involved in the biological process of cell cycle progres-
sion (decreased) or neuronal differentiation (increased). Speciﬁcally,voked by test potentials to−40 mV through−5mV from a holding potential of−80mV.
se evoked fromnon-immortalizedDPSC neurons (A). Immortalized and non-immortalized
nts evoked by test potentials to−75mV through+70mV in the same neuron depicted in
Fig. 4. A) Principal component analysis (PCA) of gene expression data from DPSCs and neurons both immortalized and non-immortalized. Light blue and light green are primary (not
immortalized) and dark blue and dark green are immortalized cells. Note that all DPSCs grouped to one side and all neurons grouped to the other side regardless of the state of
immortalization, suggesting that differentiation state is the primary component that distinguishes these samples. B) Venn diagram of signiﬁcant gene expression changes during both
differentiation and immortalization. Note that 94 transcripts changed both during differentiation andwere different between immortalized and non-immortalized neurons. Immortaliza-
tion in DPSCs appeared to have little effect with the exception of increased hTERT and decreased GAS7 transcript (two genes shared by immortalized DPSCs and immortalized neurons.
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ment scores (NES) were ≤−2 for groups of genes related to cytokinesis,
M-phase, regulation of cell cycle, cell cycle progression, interphase, DNA
replication for a total of 25 cell cycle related categories that were signif-
icantly down-regulated during the transition to neurons at an FDR of
≤0.01 (Supplemental Table 5). GSEA of the positively regulated gene
sets indicated that genes involved in nervous system development, syn-
aptic transmission, CNS development, synaptogenesis and regulation of
neurotransmitters were all enriched by ≥1.5 NES at an FDR of ≤0.13
(Supplemental Table 5). DAVID analysis of the 577 up-regulated gene
set that was up-regulated during differentiation conﬁrmed an enrich-
ment for genes that code for ion channel integral membrane proteins
and neural adhesion proteins (Enrichment Score= 4.72) as well as gly-
coproteins and signal peptides (Enrichment Score = 20.56) (Supple-
mental Table 8).
To investigate the molecular mechanisms driving the neuronal dif-
ferentiation, we performed GSEA using predicted transcription factorFig. 5. Heatmaps of transcripts that changed during differentiation into neurons. A) Heatmap
neurons. The three control DPSC lines are listed above each lane. Note that approximately equ
of 94 transcripts that changed during both differentiation and immortalization. Note that
differentiated neurons, but that expression was still not back to DPSC levels. A complete list ofbinding site data. Genes with an upstream binding site for the
Neuron-Restrictive Silencer Factor (NRSF)/RE1-silencing transcription
factor (REST) binding site were signiﬁcantly up-regulated during differ-
entiation by NES ≥ 1.9 at FDR ≤ 0.05 (Fig. 6). In fact, 16 out of 26 genes
that made up the core enrichment group were signiﬁcantly up-
regulated, including ATP2B2, a gene expressed in neurons associated
with autism spectrum disorder (Yang et al., 2013; Carayol et al.,
2011); and DRD2, which encodes a D2 type dopamine receptor that
has been associated with various nervous system disorders, including
schizophrenia (Liu et al., 2014) (Supplemental Table 5). Based on
these results, thedriving force duringdifferentiation fromDPSCs to neu-
rons appears to be regulated by the REST transcription factor. Expres-
sion analysis did not show signiﬁcant changes in the REST transcript
during differentiation (log2Fc = +0.018, Pvalue = 0.94; Supplemental
Tables 5–7). However, REST is known to be post-translationally regulat-
ed through ubiquitination and degradation during the process of dif-
ferentiation from stem cells to neurons (Huang et al., 2011), so werepresenting the 1305 transcripts that changed in primary DPSCs that differentiated into
al number of transcripts were up-regulated as down-regulated. B) Heatmap for a sub-set
immortalization of DPSCs dampened gene expression changes for these transcripts in
genes in this diagram is available in Supplemental Table 4.
Fig. 6. A) GSEA enrichment plot for transcripts with NRSF/REST transcription factor binding sites. Note that the leading edge subset of genes in this particular group containing 26
differentially regulated transcripts contributed to a peak positive enrichment score of N0.53, a normalized enrichment score of 1.9 at an FDR of b0.005. B) Gene expression changes during
differentiation for genes with REST transcription factor binding motifs. These genes were identiﬁed as enriched in the elevated gene set during the transition from DPSCs to neurons by
GSEA transcription factormotif analysis. These same geneswere elevated in hTERT immortalizedDPSC derived neurons, but to a lesser degree than in the non-immortalizedDPSCneurons.
C)Western blot for REST protein expression in DPSCs and neurons. The red signal isα-REST and the green signal is a loading control (α-GAPDH). REST protein could be detected in both
immortalized and non-immortalized DPSCs, but not in the neurons derived from these cells, despite the detection of REST transcript in both cell types. These results imply that REST
dependent transcriptional changes observed may be driven by changes in REST protein levels during the process of differentiation into neurons.
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and differentiated neurons. Fig. 6C shows that there is a dramatic
decrease in REST protein levels in neurons versus DPSCs. In fact, REST
protein isoforms could only be detected in the undifferentiated DPSCs
and not in neurons. This protein expression was not affected at all by
hTERT immortalization (Fig. 6C) and implies that the process of dif-
ferentiation is driven by down-regulation of REST protein levels in
neurons.
Next, we looked at the direction of gene expression changes for the
94 transcripts that changed both during differentiation from DPSCs
into neurons and were signiﬁcantly different between immortalized
and non-immortalized neurons (Fig. 4B). A heatmap view of these
genes during differentiation reveals that the majority of transcripts
were up-regulated in non-immortalized neurons, but then expression
levels reverted for many of these genes almost to original DPSC levels
in immortalized neurons (Fig. 5B). Further investigation of this gene
set revealed several genes involved in cell motility and adhesion. The
core sets of these genes centered around the FN1 protein and a clusterof interacting collagen proteins (COL45A, COL181A, COL25A1, and
COL23A1) (Supplemental Fig. 3). In addition, for the 189 up-regulated
transcription factor networks identiﬁed by GSEA, 129 of themwere de-
creasedwith immortalization and 60were increased further supporting
the hypothesis that at least for TFT networks there was a signiﬁcant re-
version of putative REST regulated differentiation pathways as a result
of hTERT immortalization (Fig. 6B).
4. Discussion
The objective of the current study was to characterize growth, phys-
iological andmolecular aspects of human DPSCs for the in vitro study of
patient derived DPSC neurons.We chose to evaluate DPSCs from prima-
ry teeth because studies have shown that they have the potential for
long-term cultivation, research, and possible tissue banking in the fu-
ture (Suchanek et al., 2010). Numerous studies have shown that
DPSCs can be differentiated into a variety tissue types, including neu-
rons (Arthur et al., 2008; Kiraly et al., 2009; Nosrat et al., 2004). We
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ation and it is therefore critical to understand the basic properties of
DPSCs and their differentiation into neurons if we want to use this sys-
tem as a surrogate for disease associated changes in the brains of indi-
viduals with these syndromes. Unfortunately, based on the current
study, we must conclude that constitutive expression of hTERT results
in less that fully differentiated neurons, although they appear morpho-
logically normal and have electrophysiological properties of neurons.
The global gene expression changes found for 94 transcripts in this
study indicate constitutive immortalization of DPSCs with hTERT is less
than ideal for our purposes.
Primary teeth collected from individuals with neurogenetic disor-
ders are regularly mailed to our laboratory from all around the country
in an ongoing study of neurogenetic disorders associated with autism
spectrum disorder. The temperature and time before processing can
vary greatly among samples because of this remote collection approach.
Analysis of storage conditions in this study indicates contamination by
Pen/Strep resistant bacteria was the primary reason for failure of the
DPSCs to grow and not the time after exfoliation or temperature that
the toothwas stored at prior to processing. Since initiating these studies
in the laboratory, our technical abilities have improved and our success
rate in culturing non-contaminated DPSCs is nowmuch closer to 80% of
the control teeth we receive. We achieved a slightly lower rate of non-
contaminated DPSC culture for teeth from subjects with various genetic
syndromes, possibly due to general oral hygiene issues in children with
developmental disabilities. These results indicate that we can receive
teeth from remote locations that may take days to transport, even if
they are kept at room temperature during shipping.
It should be noted that bacterial growth in DPSC cultures appeared
to loosely correlate with poor oral hygiene of our subjects. The mouth
has hundreds of species of bacteria (Aas et al., 2005), all of which may
have the potential to contaminate the media during storage even with
the addition of antibiotics to the storage media (Do et al., 2013;
Thomas and Nakaishi, 2006). It is also well known that as oral hygiene
gets worse, more pathologic ﬂora appear in the mouth (Thomas and
Nakaishi, 2006). Therefore, it is not surprising that poor oral hygiene
would lead tomore DPSC growth failures due to contamination, but fur-
ther investigation is needed to validate this theory.
Previous studies have shown that DPSCs can be cultured for several
passages without cellular senescence, but until the current study the
longevity of primary DPSCs was unknown (Suchanek et al., 2009; Yu
et al., 2010). Our results indicate that primary DPSCs are N93% senescent
by passage 13, after this crisis point, these lines may spontaneously im-
mortalize in culture or they die. Of note, Suchanek et al. reported cultur-
ing DPSC lines to the 9th passage with a 90% viability and continued
culturing to passage 20, but it appears that the determination of their vi-
ability rate was not formally measured in a senescence-associated β-
galactosidase assay, nor was their deﬁnition of viability made clear
(Suchanek et al., 2009). We also noted that as the number of passages
increased, cell morphology became poor and the density of cells while
culturing decreased, which is also contrary to their ﬁndings (Suchanek
et al., 2009).
We have now demonstrated that the hTERT retrovirus is quite effec-
tive at immortalizing DPSCs in early passages (Table 2). These immor-
talized DPSCs can be efﬁciently differentiated into neurons that are
morphologically and electrophysiologically indistinguishable to non-
immortalized DPSC neurons. They also express neuron speciﬁc markers
like MAP2 and show some residual expression of the astroglial marker
GFAP (Fig. 2B), which would be expected in a non-homogeneous cul-
ture derived from stem cells without sorting for particular lineages.
However, our molecular analysis revealed that some of the transcripts
that are elevated during the differentiation process are suppressed by
immortalization with hTERT in differentiated neurons (Fig. 3B). We
can only assume, however, that since the immortalized DPSCs can be
converted to neurons, display Na+ currents and show appropriate
down-regulation of the REST transcriptional repressor, that theseparticular transcriptsmaynot be absolutely critical to thedifferentiation
process ormay not require extremely high levels of expression for DPSC
derived neurons to be produced.
The gene expression changes that occurred during the differen-
tiation process were consistent with our expectations of changes that
must occur during neurogenesis. For example, there was a positive
enrichment for genes involved in synaptogenesis and a negative enrich-
ment for genes involved in progression of the cell cycle (see Supple-
mental Table 8 — DAVID Analysis). This is completely expected of any
cell that is transitioning from a proliferative state to a quiescent neuro-
nal state. We must be careful, however, not to assume that hTERT im-
mortalization produces DPSC derived neurons that are functionally
indistinguishable to neurons from primary DPSCs. In fact, our GSEA
analysis indicates that many transcripts with NRSF/REST transcription
factor binding sites were signiﬁcantly up-regulated during the process
of differentiation of primary DPSCs to neurons (Fig. 5A and Supplemen-
tal Table 5), despite the fact that REST transcript levels did not increase
signiﬁcantly. We can now show that REST protein is indeed down-
regulated in both immortalized and non-immortalized DPSCs during
the process of differentiation, which supports our ﬁnding of an enrich-
ment in REST regulated transcripts during the differentiation process
(Fig. 6).
However, some of the same transcripts that have REST binding site
motifs and were up-regulated during differentiation reverted back to
the previous expression levels in immortalized DPSC neurons (Fig.
6B). Furthermore, in a parallel set of experiments, we demonstrate
that both osteogenesis and adipogenesis are signiﬁcantly less efﬁcient
in constitutively hTERT immortalized DPSCs versus non-immortalized
DPSCs (El-Iyachi et al., 2015). These results lead us to conclude that con-
stitutive hTERT immortalization may not be useful for most experimen-
tal investigations of genetic disorders. Recently, Page et al. showed that
a doxycycline inducible hTERT constructs could be used to maintain
mesenchymal stem cells (MSCs) in culture long term up to p50 with
no ill effects on subsequent differentiation if the hTERT gene is turned
back off (Piper et al., 2012). One viable option for maintaining DPSCs
from subjects with rare neurogenetic disorders long term may be to
use an inducible promoter system for hTERT expression in DPSCs
which can also be turned off prior to differentiation into neurons. It
should also be noted that other methods, perhaps those recently used
to make iPSCs from DPSCs (Griesi-Oliveira et al., 2014), may also be ap-
propriate for studies involving particular syndromes. In fact, it appears
that making iPSCs from DPSCs may be more efﬁcient than making
iPSCs from ﬁbroblasts (Yan et al., 2010). Nevertheless, we will always
have the option of using primary DPSCs for our experiments, despite
the fact that this is a limited resource and especially scarcewhen study-
ing rare syndromes.
However, the utility of DPSCs is not just limited to disorders involv-
ing neuronal function. DPSCs are able to differentiate into a variety of
different cell lineages (Morad et al., 2013; Verma et al., 2014; Young
et al., 2013). In the near future, DPSCs may be used for tissue engineer-
ing, possible treatment of neural tissue injury, degenerative diseases,
and as well as regenerative dentistry. DPSCs even have the ability to in-
tegrate into host brain tissue in the mammalian brain, migrate to in-
jured areas and express neuronal speciﬁc markers as well as voltage
dependent sodium and potassium channels (Marchetto et al., 2010).
Understanding the culture conditions, characteristics, and potential of
DPSCs may prove beneﬁcial to all ﬁelds of health care. By establishing
the technical boundaries of this renewable resource, we have provided
a baseline for future studies of neurogenetic syndromes at themolecular
and cellular biological levels.
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